Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myeloid-Lymphoid Leukemia Protein | 54 | 2024 | 301 | 13.180 |
Why?
|
Histone-Lysine N-Methyltransferase | 53 | 2024 | 678 | 6.960 |
Why?
|
Leukemia | 36 | 2024 | 1520 | 6.740 |
Why?
|
Leukemia, Myeloid, Acute | 66 | 2024 | 3602 | 5.890 |
Why?
|
Gene Expression Regulation, Leukemic | 32 | 2024 | 646 | 4.840 |
Why?
|
Methyltransferases | 19 | 2018 | 374 | 4.550 |
Why?
|
Oncogene Proteins, Fusion | 35 | 2024 | 1596 | 4.170 |
Why?
|
Neoplastic Stem Cells | 28 | 2024 | 1347 | 3.440 |
Why?
|
Chromatin | 32 | 2023 | 2938 | 3.410 |
Why?
|
Histones | 33 | 2024 | 2583 | 2.540 |
Why?
|
Hematopoietic Stem Cells | 34 | 2024 | 3387 | 2.110 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 27 | 2024 | 1547 | 2.080 |
Why?
|
Proto-Oncogene Proteins | 26 | 2024 | 4490 | 2.010 |
Why?
|
Gene Rearrangement | 21 | 2022 | 1122 | 1.980 |
Why?
|
Histone Acetyltransferases | 4 | 2024 | 337 | 1.870 |
Why?
|
Homeodomain Proteins | 20 | 2021 | 2414 | 1.860 |
Why?
|
Leukemia, Biphenotypic, Acute | 6 | 2018 | 32 | 1.760 |
Why?
|
Histone Demethylases | 6 | 2023 | 323 | 1.700 |
Why?
|
Cell Transformation, Neoplastic | 19 | 2018 | 2828 | 1.660 |
Why?
|
Epigenesis, Genetic | 20 | 2022 | 3758 | 1.580 |
Why?
|
Nuclear Pore Complex Proteins | 5 | 2022 | 158 | 1.520 |
Why?
|
Transcription Factors | 38 | 2024 | 12103 | 1.510 |
Why?
|
Methylation | 21 | 2021 | 1082 | 1.450 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 5 | 2018 | 223 | 1.380 |
Why?
|
Nuclear Proteins | 15 | 2024 | 5791 | 1.240 |
Why?
|
Leukemia, Myeloid | 7 | 2020 | 695 | 1.230 |
Why?
|
Proto-Oncogenes | 8 | 2014 | 320 | 1.210 |
Why?
|
Gene Expression Regulation, Neoplastic | 21 | 2021 | 8515 | 1.090 |
Why?
|
Genes, ras | 4 | 2018 | 655 | 1.090 |
Why?
|
Leukemia, Experimental | 4 | 2020 | 225 | 1.050 |
Why?
|
Neoplasms, Experimental | 7 | 2019 | 1229 | 1.020 |
Why?
|
Mice | 106 | 2024 | 81208 | 0.980 |
Why?
|
Myeloid Progenitor Cells | 4 | 2020 | 114 | 0.980 |
Why?
|
Hematopoiesis | 10 | 2023 | 2050 | 0.970 |
Why?
|
Neoplasm Proteins | 16 | 2021 | 3610 | 0.960 |
Why?
|
fms-Like Tyrosine Kinase 3 | 10 | 2020 | 495 | 0.950 |
Why?
|
Phthalimides | 1 | 2024 | 34 | 0.930 |
Why?
|
Piperidones | 1 | 2024 | 37 | 0.920 |
Why?
|
Animals | 143 | 2024 | 167963 | 0.920 |
Why?
|
Gastrointestinal Stromal Tumors | 4 | 2022 | 615 | 0.860 |
Why?
|
Gene Expression Profiling | 32 | 2020 | 9411 | 0.860 |
Why?
|
Mutation | 36 | 2024 | 29932 | 0.850 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 3 | 2024 | 174 | 0.830 |
Why?
|
Enzyme Inhibitors | 10 | 2020 | 3726 | 0.810 |
Why?
|
Antineoplastic Agents | 23 | 2024 | 13630 | 0.780 |
Why?
|
Histone Code | 5 | 2021 | 156 | 0.740 |
Why?
|
Morpholines | 1 | 2024 | 583 | 0.730 |
Why?
|
Protein Processing, Post-Translational | 7 | 2021 | 1974 | 0.730 |
Why?
|
DNA-Binding Proteins | 20 | 2024 | 9585 | 0.710 |
Why?
|
Preleukemia | 1 | 2020 | 34 | 0.700 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2022 | 951 | 0.670 |
Why?
|
Gene Silencing | 6 | 2015 | 1513 | 0.660 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2019 | 642 | 0.650 |
Why?
|
Gene Expression | 17 | 2023 | 7588 | 0.640 |
Why?
|
beta Catenin | 5 | 2017 | 1043 | 0.640 |
Why?
|
Cell Proliferation | 26 | 2024 | 10446 | 0.630 |
Why?
|
Drug Resistance, Neoplasm | 16 | 2023 | 5253 | 0.630 |
Why?
|
Cell Line, Tumor | 40 | 2024 | 16939 | 0.620 |
Why?
|
DNA Methylation | 11 | 2020 | 4373 | 0.620 |
Why?
|
Transcription, Genetic | 14 | 2020 | 7593 | 0.610 |
Why?
|
Transcriptional Activation | 3 | 2018 | 1755 | 0.600 |
Why?
|
Sarcoma, Synovial | 1 | 2018 | 151 | 0.570 |
Why?
|
Granulocyte-Macrophage Progenitor Cells | 3 | 2017 | 21 | 0.560 |
Why?
|
Immune Evasion | 1 | 2020 | 362 | 0.550 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2018 | 286 | 0.550 |
Why?
|
Lysine | 9 | 2017 | 1001 | 0.540 |
Why?
|
Mice, Inbred C57BL | 28 | 2022 | 22023 | 0.530 |
Why?
|
Tandem Repeat Sequences | 2 | 2015 | 180 | 0.530 |
Why?
|
Molecular Targeted Therapy | 6 | 2020 | 2803 | 0.520 |
Why?
|
Genomics | 9 | 2016 | 5794 | 0.510 |
Why?
|
Cyclins | 1 | 2018 | 593 | 0.510 |
Why?
|
Humans | 179 | 2024 | 760621 | 0.510 |
Why?
|
DNA Damage | 4 | 2018 | 2442 | 0.500 |
Why?
|
Therapies, Investigational | 1 | 2016 | 112 | 0.490 |
Why?
|
Histone Deacetylase 2 | 1 | 2015 | 72 | 0.490 |
Why?
|
Acetylation | 4 | 2021 | 1062 | 0.480 |
Why?
|
Enhancer Elements, Genetic | 4 | 2018 | 1356 | 0.480 |
Why?
|
Oncogenes | 4 | 2017 | 1220 | 0.480 |
Why?
|
Indomethacin | 2 | 2012 | 326 | 0.470 |
Why?
|
Oligonucleotide Array Sequence Analysis | 9 | 2009 | 3775 | 0.470 |
Why?
|
Histone Deacetylase 1 | 1 | 2015 | 134 | 0.470 |
Why?
|
Neoplasms | 14 | 2021 | 22072 | 0.460 |
Why?
|
Gene Duplication | 2 | 2015 | 313 | 0.460 |
Why?
|
DNA, Neoplasm | 5 | 2017 | 1745 | 0.450 |
Why?
|
GATA2 Transcription Factor | 1 | 2014 | 158 | 0.450 |
Why?
|
Janus Kinase 2 | 5 | 2021 | 542 | 0.450 |
Why?
|
Sirtuin 1 | 1 | 2015 | 247 | 0.450 |
Why?
|
Histone Deacetylase Inhibitors | 3 | 2016 | 772 | 0.450 |
Why?
|
Chromosome Inversion | 1 | 2014 | 120 | 0.440 |
Why?
|
Receptor Protein-Tyrosine Kinases | 6 | 2022 | 1613 | 0.440 |
Why?
|
Chromosome Aberrations | 6 | 2019 | 1764 | 0.430 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2014 | 315 | 0.430 |
Why?
|
Hematologic Neoplasms | 6 | 2024 | 1895 | 0.420 |
Why?
|
Epigenomics | 3 | 2023 | 936 | 0.420 |
Why?
|
Apoptosis | 17 | 2021 | 9501 | 0.420 |
Why?
|
Drug Delivery Systems | 4 | 2017 | 2221 | 0.410 |
Why?
|
Myosins | 1 | 2013 | 405 | 0.380 |
Why?
|
Trans-Activators | 4 | 2018 | 2860 | 0.370 |
Why?
|
Receptors, Notch | 3 | 2014 | 743 | 0.360 |
Why?
|
Cell Differentiation | 18 | 2022 | 11481 | 0.360 |
Why?
|
Xenograft Model Antitumor Assays | 14 | 2024 | 3584 | 0.360 |
Why?
|
Tumor Cells, Cultured | 11 | 2021 | 6131 | 0.360 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2012 | 364 | 0.350 |
Why?
|
Haploinsufficiency | 3 | 2022 | 329 | 0.350 |
Why?
|
Signal Transduction | 16 | 2024 | 23376 | 0.340 |
Why?
|
Multiprotein Complexes | 2 | 2014 | 1120 | 0.340 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2012 | 685 | 0.340 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 5 | 2018 | 1407 | 0.340 |
Why?
|
Myelopoiesis | 3 | 2017 | 134 | 0.330 |
Why?
|
Wnt Proteins | 2 | 2011 | 719 | 0.330 |
Why?
|
Mice, Mutant Strains | 5 | 2020 | 1753 | 0.330 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2019 | 2919 | 0.320 |
Why?
|
Cell Survival | 13 | 2019 | 5797 | 0.320 |
Why?
|
Genome, Human | 6 | 2021 | 4417 | 0.310 |
Why?
|
Proto-Oncogene Proteins c-kit | 3 | 2022 | 727 | 0.310 |
Why?
|
Cell Lineage | 10 | 2015 | 2533 | 0.300 |
Why?
|
Treatment Failure | 1 | 2014 | 2648 | 0.300 |
Why?
|
Proto-Oncogene Proteins c-myc | 4 | 2021 | 995 | 0.290 |
Why?
|
Proto-Oncogene Proteins c-abl | 1 | 2008 | 140 | 0.290 |
Why?
|
Myelodysplastic Syndromes | 2 | 2016 | 1394 | 0.290 |
Why?
|
Protein Binding | 10 | 2023 | 9335 | 0.290 |
Why?
|
Mice, Transgenic | 12 | 2021 | 9530 | 0.290 |
Why?
|
HEK293 Cells | 9 | 2019 | 4264 | 0.280 |
Why?
|
Cytoskeletal Proteins | 1 | 2012 | 1343 | 0.280 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2014 | 2058 | 0.280 |
Why?
|
Adult Stem Cells | 2 | 2009 | 221 | 0.280 |
Why?
|
Cell Cycle | 5 | 2018 | 2934 | 0.280 |
Why?
|
RNA, Small Interfering | 11 | 2017 | 3442 | 0.270 |
Why?
|
Transposases | 2 | 2017 | 103 | 0.270 |
Why?
|
PTEN Phosphohydrolase | 1 | 2012 | 1115 | 0.270 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 13 | 2016 | 4573 | 0.270 |
Why?
|
Embryonic Stem Cells | 2 | 2017 | 1262 | 0.270 |
Why?
|
Mice, Knockout | 15 | 2021 | 14372 | 0.270 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2008 | 431 | 0.260 |
Why?
|
Chromatin Immunoprecipitation | 4 | 2015 | 858 | 0.250 |
Why?
|
Protein Array Analysis | 1 | 2007 | 401 | 0.250 |
Why?
|
Flow Cytometry | 6 | 2016 | 5870 | 0.250 |
Why?
|
Piperazines | 4 | 2012 | 2525 | 0.240 |
Why?
|
Astrocytes | 1 | 2012 | 1338 | 0.240 |
Why?
|
Lymphoproliferative Disorders | 1 | 2008 | 533 | 0.240 |
Why?
|
Translocation, Genetic | 4 | 2010 | 1388 | 0.230 |
Why?
|
Benzimidazoles | 2 | 2020 | 858 | 0.230 |
Why?
|
Class Ib Phosphatidylinositol 3-Kinase | 1 | 2024 | 43 | 0.230 |
Why?
|
Pentose Phosphate Pathway | 1 | 2024 | 126 | 0.220 |
Why?
|
Dioxygenases | 2 | 2024 | 335 | 0.220 |
Why?
|
Disease Models, Animal | 14 | 2024 | 18137 | 0.220 |
Why?
|
Epithelium | 1 | 2008 | 1605 | 0.220 |
Why?
|
Gene Knockdown Techniques | 3 | 2018 | 1617 | 0.210 |
Why?
|
Staurosporine | 2 | 2005 | 242 | 0.210 |
Why?
|
Pyrimidines | 3 | 2014 | 3016 | 0.210 |
Why?
|
Repressor Proteins | 3 | 2015 | 2981 | 0.210 |
Why?
|
RNA Interference | 7 | 2017 | 2846 | 0.210 |
Why?
|
Glucocorticoids | 4 | 2010 | 2145 | 0.210 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2023 | 698 | 0.210 |
Why?
|
Phenylurea Compounds | 3 | 2015 | 529 | 0.200 |
Why?
|
MicroRNAs | 4 | 2017 | 3790 | 0.200 |
Why?
|
Transcriptional Elongation Factors | 2 | 2017 | 163 | 0.200 |
Why?
|
Blotting, Western | 8 | 2015 | 5039 | 0.200 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 1 | 2022 | 101 | 0.200 |
Why?
|
Protein Kinase Inhibitors | 6 | 2020 | 5643 | 0.200 |
Why?
|
Genes, Neoplasm | 2 | 2015 | 370 | 0.200 |
Why?
|
Transcription Factor TFIIA | 1 | 2021 | 17 | 0.200 |
Why?
|
Oncogene Proteins | 2 | 2016 | 719 | 0.200 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2021 | 1139 | 0.200 |
Why?
|
Plateletpheresis | 1 | 2001 | 38 | 0.200 |
Why?
|
Stem Cell Niche | 3 | 2017 | 346 | 0.190 |
Why?
|
Y-Box-Binding Protein 1 | 1 | 2021 | 41 | 0.190 |
Why?
|
Ubiquitination | 2 | 2021 | 1008 | 0.190 |
Why?
|
Coxiella burnetii | 1 | 2021 | 37 | 0.190 |
Why?
|
Gene Knock-In Techniques | 2 | 2020 | 419 | 0.190 |
Why?
|
Q Fever | 1 | 2021 | 38 | 0.190 |
Why?
|
Genome | 3 | 2015 | 1739 | 0.180 |
Why?
|
Ikaros Transcription Factor | 1 | 2022 | 231 | 0.180 |
Why?
|
Gene Deletion | 4 | 2019 | 2668 | 0.180 |
Why?
|
Mice, SCID | 4 | 2024 | 2627 | 0.180 |
Why?
|
STAT Transcription Factors | 1 | 2021 | 188 | 0.180 |
Why?
|
Adenosine | 3 | 2015 | 834 | 0.180 |
Why?
|
Models, Genetic | 3 | 2016 | 3442 | 0.180 |
Why?
|
Cytidine Deaminase | 1 | 2022 | 245 | 0.180 |
Why?
|
Neoplasm Transplantation | 3 | 2016 | 2014 | 0.180 |
Why?
|
Sirolimus | 2 | 2006 | 1547 | 0.170 |
Why?
|
Janus Kinases | 1 | 2021 | 250 | 0.170 |
Why?
|
Molecular Sequence Data | 12 | 2014 | 17624 | 0.170 |
Why?
|
Computational Biology | 1 | 2012 | 3505 | 0.170 |
Why?
|
Cytarabine | 3 | 2017 | 696 | 0.170 |
Why?
|
Tumor Suppressor Proteins | 5 | 2016 | 2802 | 0.170 |
Why?
|
Germinal Center | 1 | 2022 | 379 | 0.170 |
Why?
|
Blood Donors | 1 | 2001 | 343 | 0.170 |
Why?
|
Thrombopoietin | 1 | 2001 | 226 | 0.170 |
Why?
|
Immunophenotyping | 4 | 2016 | 1871 | 0.170 |
Why?
|
bcl-X Protein | 1 | 2021 | 413 | 0.160 |
Why?
|
Databases, Genetic | 3 | 2012 | 1738 | 0.160 |
Why?
|
E1A-Associated p300 Protein | 2 | 2017 | 123 | 0.160 |
Why?
|
Peptoids | 1 | 2018 | 7 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2019 | 191 | 0.160 |
Why?
|
Cells, Cultured | 12 | 2019 | 18957 | 0.160 |
Why?
|
Protein Stability | 2 | 2018 | 566 | 0.160 |
Why?
|
HL-60 Cells | 3 | 2018 | 363 | 0.160 |
Why?
|
Binding Sites | 6 | 2023 | 6048 | 0.160 |
Why?
|
Janus Kinase 1 | 2 | 2016 | 107 | 0.160 |
Why?
|
Promoter Regions, Genetic | 6 | 2019 | 5785 | 0.160 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2023 | 421 | 0.160 |
Why?
|
Platelet Transfusion | 1 | 2001 | 294 | 0.160 |
Why?
|
Protein Methyltransferases | 2 | 2008 | 54 | 0.160 |
Why?
|
Base Sequence | 8 | 2016 | 12446 | 0.160 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2024 | 929 | 0.150 |
Why?
|
Benzodioxoles | 2 | 2015 | 75 | 0.150 |
Why?
|
Granulocytes | 3 | 2017 | 551 | 0.150 |
Why?
|
Peptidomimetics | 1 | 2018 | 31 | 0.150 |
Why?
|
Green Fluorescent Proteins | 3 | 2015 | 2057 | 0.150 |
Why?
|
Disease Progression | 5 | 2018 | 13502 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2018 | 79 | 0.150 |
Why?
|
Glioma | 1 | 2012 | 3420 | 0.150 |
Why?
|
Endopeptidases | 1 | 2021 | 772 | 0.150 |
Why?
|
Biocatalysis | 1 | 2018 | 172 | 0.150 |
Why?
|
Fanconi Anemia Complementation Group D2 Protein | 1 | 2018 | 146 | 0.140 |
Why?
|
Benzamides | 3 | 2019 | 1369 | 0.140 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2017 | 69 | 0.140 |
Why?
|
MAP Kinase Signaling System | 2 | 2021 | 1484 | 0.140 |
Why?
|
Protein Interaction Mapping | 1 | 2020 | 617 | 0.140 |
Why?
|
p300-CBP Transcription Factors | 1 | 2018 | 150 | 0.140 |
Why?
|
Epitopes | 1 | 2023 | 2503 | 0.140 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2023 | 2299 | 0.140 |
Why?
|
Transferases | 2 | 1993 | 72 | 0.140 |
Why?
|
Sp1 Transcription Factor | 1 | 1997 | 140 | 0.140 |
Why?
|
Blood Cells | 3 | 2016 | 305 | 0.140 |
Why?
|
RNA, Messenger | 8 | 2018 | 12766 | 0.140 |
Why?
|
Insect Proteins | 2 | 2014 | 254 | 0.140 |
Why?
|
RNA, Neoplasm | 3 | 2016 | 749 | 0.140 |
Why?
|
Antigen Presentation | 1 | 2022 | 1254 | 0.140 |
Why?
|
Response Elements | 1 | 2018 | 308 | 0.140 |
Why?
|
Leukemia, Lymphoid | 2 | 2008 | 310 | 0.140 |
Why?
|
Alkyl and Aryl Transferases | 2 | 1993 | 86 | 0.130 |
Why?
|
Uterus | 1 | 2020 | 651 | 0.130 |
Why?
|
Biomimetic Materials | 1 | 2018 | 173 | 0.130 |
Why?
|
Leiomyosarcoma | 1 | 2020 | 424 | 0.130 |
Why?
|
Retroviridae | 1 | 2018 | 850 | 0.130 |
Why?
|
DNA Fingerprinting | 1 | 2016 | 111 | 0.130 |
Why?
|
Immunoprecipitation | 4 | 2016 | 877 | 0.130 |
Why?
|
Cyclin-Dependent Kinase 8 | 1 | 2015 | 48 | 0.130 |
Why?
|
Fetal Development | 1 | 2021 | 766 | 0.130 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2016 | 454 | 0.130 |
Why?
|
Recombinant Proteins | 3 | 2017 | 6538 | 0.130 |
Why?
|
Polyethylene Glycols | 1 | 2001 | 1189 | 0.130 |
Why?
|
Point Mutation | 3 | 2010 | 1594 | 0.130 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2017 | 633 | 0.130 |
Why?
|
Spliceosomes | 1 | 2016 | 129 | 0.130 |
Why?
|
Transfection | 6 | 2017 | 5781 | 0.130 |
Why?
|
Genes, Homeobox | 2 | 2010 | 284 | 0.120 |
Why?
|
Purines | 2 | 2015 | 605 | 0.120 |
Why?
|
Oxidoreductases, N-Demethylating | 1 | 2015 | 110 | 0.120 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2016 | 381 | 0.120 |
Why?
|
Rhabdoid Tumor | 1 | 2017 | 210 | 0.120 |
Why?
|
Phosphoproteins | 1 | 2024 | 2440 | 0.120 |
Why?
|
Ribosomal Proteins | 1 | 2017 | 363 | 0.120 |
Why?
|
Selection, Genetic | 1 | 2019 | 869 | 0.120 |
Why?
|
Retinal Diseases | 1 | 2021 | 702 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2024 | 2448 | 0.120 |
Why?
|
Models, Biological | 5 | 2020 | 9467 | 0.120 |
Why?
|
Anthracyclines | 1 | 2016 | 283 | 0.120 |
Why?
|
Immunotherapy | 2 | 2023 | 4642 | 0.120 |
Why?
|
B-Lymphocytes | 4 | 2022 | 4742 | 0.120 |
Why?
|
Aphids | 1 | 2014 | 6 | 0.120 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2015 | 423 | 0.120 |
Why?
|
Cyclin-Dependent Kinase 9 | 1 | 2014 | 67 | 0.120 |
Why?
|
Myeloproliferative Disorders | 2 | 2014 | 609 | 0.120 |
Why?
|
Forkhead Transcription Factors | 3 | 2014 | 1612 | 0.120 |
Why?
|
Bone Marrow Cells | 4 | 2014 | 2414 | 0.120 |
Why?
|
Gene Expression Regulation | 4 | 2013 | 11903 | 0.120 |
Why?
|
CREB-Binding Protein | 3 | 2011 | 148 | 0.120 |
Why?
|
Wet Macular Degeneration | 1 | 2016 | 162 | 0.110 |
Why?
|
Immunoblotting | 6 | 2016 | 1649 | 0.110 |
Why?
|
Abnormalities, Multiple | 1 | 2021 | 1415 | 0.110 |
Why?
|
Down-Regulation | 4 | 2018 | 2913 | 0.110 |
Why?
|
Homeostasis | 4 | 2013 | 3306 | 0.110 |
Why?
|
Neuroblastoma | 1 | 2022 | 1252 | 0.110 |
Why?
|
Bone Marrow Transplantation | 4 | 2023 | 2693 | 0.110 |
Why?
|
Carrier Proteins | 4 | 2014 | 4938 | 0.110 |
Why?
|
Liver Neoplasms | 2 | 2023 | 4319 | 0.110 |
Why?
|
Antifungal Agents | 1 | 2018 | 749 | 0.110 |
Why?
|
Thrombocytopenia | 1 | 2001 | 1174 | 0.110 |
Why?
|
Proteomics | 3 | 2023 | 3817 | 0.110 |
Why?
|
Neurons | 1 | 2012 | 9426 | 0.110 |
Why?
|
Research Report | 1 | 2016 | 370 | 0.110 |
Why?
|
DNA Mutational Analysis | 5 | 2016 | 4107 | 0.110 |
Why?
|
Recurrence | 4 | 2023 | 8482 | 0.110 |
Why?
|
Female | 37 | 2021 | 391270 | 0.110 |
Why?
|
Clinical Trials as Topic | 3 | 2016 | 8056 | 0.110 |
Why?
|
Uveal Neoplasms | 1 | 2016 | 341 | 0.110 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2012 | 503 | 0.110 |
Why?
|
Integrin beta3 | 1 | 2013 | 121 | 0.110 |
Why?
|
Prognosis | 8 | 2023 | 29658 | 0.110 |
Why?
|
Early Growth Response Protein 1 | 1 | 2012 | 132 | 0.110 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 4 | 2015 | 351 | 0.100 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2017 | 895 | 0.100 |
Why?
|
Phenotype | 3 | 2021 | 16546 | 0.100 |
Why?
|
Niacinamide | 1 | 2014 | 414 | 0.100 |
Why?
|
Quadriplegia | 1 | 2014 | 226 | 0.100 |
Why?
|
Mutation, Missense | 2 | 2019 | 2566 | 0.100 |
Why?
|
Cell Division | 3 | 2015 | 4463 | 0.100 |
Why?
|
DNA | 3 | 2005 | 7233 | 0.100 |
Why?
|
Genetic Loci | 2 | 2012 | 2618 | 0.100 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2015 | 2418 | 0.100 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2015 | 656 | 0.100 |
Why?
|
Ligands | 5 | 2023 | 3276 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2020 | 11712 | 0.100 |
Why?
|
Monomeric Clathrin Assembly Proteins | 1 | 2011 | 24 | 0.100 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2014 | 269 | 0.100 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 877 | 0.100 |
Why?
|
Survival Analysis | 4 | 2017 | 10182 | 0.100 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2012 | 225 | 0.100 |
Why?
|
Cytoprotection | 1 | 2012 | 200 | 0.100 |
Why?
|
Polycythemia Vera | 1 | 2013 | 160 | 0.100 |
Why?
|
Genetic Testing | 3 | 2021 | 3531 | 0.100 |
Why?
|
DNA Primers | 2 | 2014 | 2819 | 0.100 |
Why?
|
RNA | 2 | 2020 | 2722 | 0.100 |
Why?
|
Mice, Inbred NOD | 3 | 2021 | 1837 | 0.100 |
Why?
|
Acute Disease | 5 | 2016 | 7269 | 0.090 |
Why?
|
Alleles | 3 | 2015 | 6898 | 0.090 |
Why?
|
Child | 17 | 2022 | 79806 | 0.090 |
Why?
|
Brain Neoplasms | 1 | 2012 | 8986 | 0.090 |
Why?
|
Transduction, Genetic | 2 | 2014 | 897 | 0.090 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2014 | 346 | 0.090 |
Why?
|
Prostaglandins | 1 | 2012 | 398 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 2 | 2012 | 2471 | 0.090 |
Why?
|
Database Management Systems | 1 | 2012 | 258 | 0.090 |
Why?
|
Bone Marrow | 4 | 2022 | 2912 | 0.090 |
Why?
|
Cell Line | 7 | 2018 | 15620 | 0.090 |
Why?
|
Phosphorylation | 6 | 2020 | 8313 | 0.090 |
Why?
|
Trichostrongyloidiasis | 1 | 2010 | 1 | 0.090 |
Why?
|
Trichostrongyloidea | 1 | 2010 | 2 | 0.090 |
Why?
|
RNA-Binding Proteins | 2 | 2017 | 1894 | 0.090 |
Why?
|
Sheep Diseases | 1 | 2010 | 18 | 0.090 |
Why?
|
Histone Deacetylases | 1 | 2015 | 718 | 0.090 |
Why?
|
Economic Competition | 1 | 2012 | 218 | 0.090 |
Why?
|
Nitrophenols | 2 | 2007 | 169 | 0.090 |
Why?
|
Immunoglobulin A, Secretory | 1 | 2010 | 104 | 0.090 |
Why?
|
Graft vs Tumor Effect | 1 | 2010 | 68 | 0.090 |
Why?
|
U937 Cells | 2 | 2021 | 262 | 0.090 |
Why?
|
Computer Graphics | 1 | 2012 | 341 | 0.090 |
Why?
|
Clathrin | 1 | 2011 | 257 | 0.090 |
Why?
|
Drug Design | 2 | 2007 | 1061 | 0.090 |
Why?
|
Cost Control | 1 | 2012 | 630 | 0.090 |
Why?
|
Small Molecule Libraries | 2 | 2015 | 734 | 0.080 |
Why?
|
Telomerase | 1 | 2014 | 746 | 0.080 |
Why?
|
Computers | 1 | 2012 | 595 | 0.080 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2012 | 5649 | 0.080 |
Why?
|
Fetus | 1 | 2016 | 1859 | 0.080 |
Why?
|
Helminth Proteins | 1 | 2010 | 172 | 0.080 |
Why?
|
Galectin 1 | 1 | 2010 | 128 | 0.080 |
Why?
|
Myogenic Regulatory Factors | 1 | 2009 | 103 | 0.080 |
Why?
|
High-Throughput Screening Assays | 1 | 2015 | 944 | 0.080 |
Why?
|
Genetic Vectors | 1 | 2018 | 3380 | 0.080 |
Why?
|
Software | 3 | 2012 | 4419 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2015 | 10827 | 0.080 |
Why?
|
Receptors, Estrogen | 1 | 2017 | 2210 | 0.080 |
Why?
|
Membrane Transport Proteins | 1 | 2014 | 1035 | 0.080 |
Why?
|
Melatonin | 1 | 2014 | 668 | 0.080 |
Why?
|
Interferon-alpha | 1 | 2013 | 918 | 0.080 |
Why?
|
Sequence Deletion | 2 | 2022 | 1493 | 0.080 |
Why?
|
Infant | 11 | 2017 | 36060 | 0.080 |
Why?
|
Validation Studies as Topic | 1 | 2008 | 162 | 0.080 |
Why?
|
User-Computer Interface | 2 | 2012 | 1403 | 0.080 |
Why?
|
K562 Cells | 2 | 2020 | 640 | 0.080 |
Why?
|
Amino Acid Sequence | 8 | 2015 | 13451 | 0.080 |
Why?
|
Lymphopoiesis | 1 | 2009 | 133 | 0.080 |
Why?
|
Antioxidants | 2 | 2014 | 1667 | 0.080 |
Why?
|
Sequence Analysis, DNA | 3 | 2016 | 4713 | 0.080 |
Why?
|
Exons | 1 | 2014 | 2388 | 0.080 |
Why?
|
Reed-Sternberg Cells | 1 | 2008 | 72 | 0.070 |
Why?
|
Gene Expression Regulation, Developmental | 4 | 2024 | 3604 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2007 | 15789 | 0.070 |
Why?
|
Annexin A5 | 2 | 2007 | 103 | 0.070 |
Why?
|
Thrombopoiesis | 1 | 2009 | 164 | 0.070 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2010 | 415 | 0.070 |
Why?
|
Mice, Nude | 3 | 2019 | 3607 | 0.070 |
Why?
|
Listeria monocytogenes | 1 | 2009 | 248 | 0.070 |
Why?
|
Blotting, Southern | 1 | 2007 | 777 | 0.070 |
Why?
|
Gene Knockout Techniques | 3 | 2015 | 802 | 0.070 |
Why?
|
Leukemia, Myelomonocytic, Acute | 1 | 2006 | 38 | 0.070 |
Why?
|
Reimbursement Mechanisms | 1 | 2012 | 664 | 0.070 |
Why?
|
Indoles | 1 | 2014 | 1829 | 0.070 |
Why?
|
Antigens, CD34 | 2 | 2023 | 653 | 0.070 |
Why?
|
Acid Anhydride Hydrolases | 1 | 2006 | 66 | 0.070 |
Why?
|
Angiogenesis Inhibitors | 1 | 2016 | 2049 | 0.070 |
Why?
|
Integrases | 1 | 2008 | 516 | 0.070 |
Why?
|
Drug Synergism | 2 | 2020 | 1754 | 0.070 |
Why?
|
Hedgehog Proteins | 2 | 2009 | 769 | 0.070 |
Why?
|
Prednisolone | 1 | 2007 | 327 | 0.060 |
Why?
|
Luciferases | 1 | 2007 | 716 | 0.060 |
Why?
|
Lymphoma, T-Cell | 1 | 2008 | 305 | 0.060 |
Why?
|
Biphenyl Compounds | 2 | 2007 | 992 | 0.060 |
Why?
|
Hep G2 Cells | 2 | 2018 | 389 | 0.060 |
Why?
|
Principal Component Analysis | 1 | 2008 | 940 | 0.060 |
Why?
|
Mitochondria, Liver | 1 | 2006 | 190 | 0.060 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 1 | 2005 | 112 | 0.060 |
Why?
|
Dexamethasone | 3 | 2009 | 1927 | 0.060 |
Why?
|
Hyaluronic Acid | 3 | 1993 | 482 | 0.060 |
Why?
|
Leukemia, B-Cell | 1 | 2005 | 84 | 0.060 |
Why?
|
Macrophages | 3 | 2017 | 5745 | 0.060 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2019 | 1693 | 0.060 |
Why?
|
Precancerous Conditions | 1 | 2012 | 977 | 0.060 |
Why?
|
NIH 3T3 Cells | 2 | 2018 | 670 | 0.060 |
Why?
|
Prednisone | 1 | 2009 | 1565 | 0.060 |
Why?
|
Genes, Immunoglobulin | 1 | 2005 | 285 | 0.060 |
Why?
|
Loss of Heterozygosity | 1 | 2007 | 659 | 0.060 |
Why?
|
Microsatellite Repeats | 1 | 2007 | 786 | 0.060 |
Why?
|
Nuclear Receptor Coactivator 2 | 1 | 2024 | 40 | 0.060 |
Why?
|
Kinetics | 1 | 2012 | 6377 | 0.060 |
Why?
|
Megakaryocytes | 1 | 2009 | 565 | 0.060 |
Why?
|
bcl-2-Associated X Protein | 1 | 2005 | 282 | 0.060 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2005 | 2506 | 0.060 |
Why?
|
Up-Regulation | 2 | 2015 | 4122 | 0.060 |
Why?
|
Child, Preschool | 8 | 2017 | 42063 | 0.060 |
Why?
|
Proteome | 1 | 2014 | 1855 | 0.060 |
Why?
|
Diploidy | 1 | 2003 | 132 | 0.060 |
Why?
|
Proteins | 1 | 2019 | 6029 | 0.060 |
Why?
|
Male | 27 | 2021 | 359744 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 1 | 2005 | 17790 | 0.060 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2023 | 84 | 0.050 |
Why?
|
Colony-Forming Units Assay | 2 | 2014 | 351 | 0.050 |
Why?
|
Antigens, Bacterial | 1 | 2009 | 1155 | 0.050 |
Why?
|
Models, Molecular | 3 | 2021 | 5434 | 0.050 |
Why?
|
Leukemia, T-Cell | 1 | 2003 | 101 | 0.050 |
Why?
|
Acetyltransferases | 1 | 2024 | 231 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2012 | 2895 | 0.050 |
Why?
|
Internet | 2 | 2012 | 3078 | 0.050 |
Why?
|
Epitope Mapping | 1 | 2023 | 297 | 0.050 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2006 | 1347 | 0.050 |
Why?
|
Survival Rate | 3 | 2021 | 12808 | 0.050 |
Why?
|
Systems Integration | 2 | 2016 | 426 | 0.050 |
Why?
|
Genes, Tumor Suppressor | 2 | 2017 | 1055 | 0.050 |
Why?
|
Intestinal Mucosa | 1 | 2013 | 3022 | 0.050 |
Why?
|
Molecular Biology | 1 | 2005 | 580 | 0.050 |
Why?
|
Ubiquitins | 1 | 2023 | 370 | 0.050 |
Why?
|
Interleukin-3 | 1 | 2003 | 425 | 0.050 |
Why?
|
Neoplasm, Residual | 2 | 2023 | 1007 | 0.050 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2024 | 376 | 0.050 |
Why?
|
Structure-Activity Relationship | 2 | 2018 | 3084 | 0.050 |
Why?
|
Osteoarthritis | 3 | 1993 | 1055 | 0.050 |
Why?
|
Remission Induction | 2 | 2023 | 2392 | 0.050 |
Why?
|
Sulfonamides | 2 | 2007 | 1977 | 0.050 |
Why?
|
Flavonols | 1 | 2021 | 83 | 0.050 |
Why?
|
Sheep | 6 | 2010 | 1441 | 0.040 |
Why?
|
Tumor Escape | 1 | 2023 | 370 | 0.040 |
Why?
|
Drug Combinations | 1 | 2006 | 2025 | 0.040 |
Why?
|
Inflammation | 1 | 2020 | 10756 | 0.040 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2012 | 1846 | 0.040 |
Why?
|
Diphenylamine | 1 | 2019 | 49 | 0.040 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 2012 | 410 | 0.040 |
Why?
|
Insurance, Health | 1 | 2012 | 2501 | 0.040 |
Why?
|
Health Expenditures | 1 | 2012 | 2362 | 0.040 |
Why?
|
Ciprofloxacin | 1 | 2021 | 312 | 0.040 |
Why?
|
Doxycycline | 1 | 2021 | 341 | 0.040 |
Why?
|
Antibodies, Monoclonal | 2 | 2023 | 9185 | 0.040 |
Why?
|
Adult | 12 | 2022 | 219994 | 0.040 |
Why?
|
Heterocyclic Compounds, 2-Ring | 1 | 2019 | 38 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2016 | 3616 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2020 | 736 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13262 | 0.040 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 224 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2021 | 717 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2023 | 854 | 0.040 |
Why?
|
Platelet Count | 1 | 2001 | 777 | 0.040 |
Why?
|
Drugs, Investigational | 1 | 2020 | 214 | 0.040 |
Why?
|
Clone Cells | 1 | 2022 | 1660 | 0.040 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2007 | 1529 | 0.040 |
Why?
|
Protein Kinase C | 1 | 2003 | 1199 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2019 | 326 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2019 | 478 | 0.040 |
Why?
|
Indazoles | 1 | 2019 | 302 | 0.040 |
Why?
|
Cryptococcus neoformans | 1 | 2018 | 121 | 0.040 |
Why?
|
Okadaic Acid | 1 | 1997 | 67 | 0.040 |
Why?
|
Antigens, Neoplasm | 1 | 2005 | 1998 | 0.040 |
Why?
|
Phospholipase D | 1 | 1997 | 67 | 0.040 |
Why?
|
Parkinson Disease | 1 | 2011 | 2859 | 0.040 |
Why?
|
Melanoma | 1 | 2016 | 5697 | 0.040 |
Why?
|
Homozygote | 1 | 2022 | 1788 | 0.040 |
Why?
|
Chromosome Breakpoints | 1 | 2017 | 93 | 0.040 |
Why?
|
Hydrazones | 1 | 2017 | 102 | 0.040 |
Why?
|
Terminal Repeat Sequences | 1 | 2017 | 70 | 0.040 |
Why?
|
Stromal Cells | 2 | 2014 | 1326 | 0.040 |
Why?
|
Mammals | 1 | 2023 | 1131 | 0.040 |
Why?
|
Tacrolimus | 1 | 2021 | 733 | 0.040 |
Why?
|
Mutagenesis | 1 | 2021 | 1234 | 0.040 |
Why?
|
Cell Cycle Proteins | 3 | 2015 | 3446 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2019 | 629 | 0.040 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 2 | 2007 | 88 | 0.030 |
Why?
|
Models, Animal | 1 | 2003 | 2117 | 0.030 |
Why?
|
Casein Kinase II | 1 | 1997 | 122 | 0.030 |
Why?
|
Azepines | 1 | 2019 | 330 | 0.030 |
Why?
|
Medical Oncology | 2 | 2020 | 2313 | 0.030 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 2016 | 69 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2020 | 1342 | 0.030 |
Why?
|
Safety | 1 | 2001 | 1148 | 0.030 |
Why?
|
Daunorubicin | 1 | 2016 | 156 | 0.030 |
Why?
|
Databases, Factual | 2 | 2016 | 8035 | 0.030 |
Why?
|
Hemizygote | 1 | 2016 | 28 | 0.030 |
Why?
|
Genes, Dominant | 1 | 2019 | 863 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2017 | 165 | 0.030 |
Why?
|
Cartilage, Articular | 3 | 1993 | 1091 | 0.030 |
Why?
|
Transplantation Conditioning | 1 | 2023 | 1588 | 0.030 |
Why?
|
Mass Spectrometry | 2 | 2016 | 2192 | 0.030 |
Why?
|
Gene Amplification | 1 | 2001 | 1085 | 0.030 |
Why?
|
Thiazoles | 2 | 2019 | 1511 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2019 | 814 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2018 | 367 | 0.030 |
Why?
|
Precursor Cells, T-Lymphoid | 1 | 2016 | 19 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14660 | 0.030 |
Why?
|
Random Allocation | 1 | 2020 | 2394 | 0.030 |
Why?
|
Mice, Inbred Strains | 2 | 2015 | 1763 | 0.030 |
Why?
|
Gene Targeting | 1 | 2019 | 839 | 0.030 |
Why?
|
Polycyclic Compounds | 1 | 2015 | 29 | 0.030 |
Why?
|
Drug Discovery | 1 | 2024 | 1057 | 0.030 |
Why?
|
Epoxy Compounds | 1 | 2016 | 137 | 0.030 |
Why?
|
Femur | 2 | 2011 | 1302 | 0.030 |
Why?
|
Protein Sorting Signals | 1 | 2016 | 279 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2007 | 3106 | 0.030 |
Why?
|
Cattle | 3 | 2016 | 3847 | 0.030 |
Why?
|
Interferon Regulatory Factors | 1 | 2017 | 260 | 0.030 |
Why?
|
Liver Regeneration | 1 | 1997 | 213 | 0.030 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2016 | 95 | 0.030 |
Why?
|
Sequence Analysis, Protein | 1 | 2016 | 258 | 0.030 |
Why?
|
Proteoglycans | 3 | 1993 | 801 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2021 | 1674 | 0.030 |
Why?
|
Hydrogen Bonding | 1 | 2015 | 291 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 2023 | 10181 | 0.030 |
Why?
|
E2F Transcription Factors | 1 | 2015 | 269 | 0.030 |
Why?
|
Amino Acid Substitution | 2 | 2013 | 1737 | 0.030 |
Why?
|
Macrolides | 1 | 2016 | 206 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 2 | 1995 | 778 | 0.030 |
Why?
|
Proline | 1 | 2016 | 457 | 0.030 |
Why?
|
Feedback, Physiological | 1 | 2017 | 476 | 0.030 |
Why?
|
Molecular Dynamics Simulation | 1 | 2018 | 435 | 0.030 |
Why?
|
Catalytic Domain | 1 | 2017 | 706 | 0.030 |
Why?
|
Retreatment | 1 | 2016 | 600 | 0.030 |
Why?
|
Buchnera | 1 | 2014 | 1 | 0.030 |
Why?
|
Positive Transcriptional Elongation Factor B | 1 | 2014 | 42 | 0.030 |
Why?
|
Intravitreal Injections | 1 | 2016 | 384 | 0.030 |
Why?
|
Arabidopsis | 1 | 1998 | 464 | 0.030 |
Why?
|
Receptors, Interleukin-6 | 1 | 2016 | 226 | 0.030 |
Why?
|
Carcinogens | 1 | 2016 | 449 | 0.030 |
Why?
|
Poaceae | 1 | 2014 | 26 | 0.030 |
Why?
|
Protein Kinase C-alpha | 1 | 2014 | 113 | 0.030 |
Why?
|
Catalysis | 1 | 2016 | 775 | 0.030 |
Why?
|
Bone Marrow Diseases | 1 | 2016 | 232 | 0.030 |
Why?
|
Anemia, Aplastic | 1 | 2016 | 228 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2014 | 12427 | 0.030 |
Why?
|
Endothelial Cells | 2 | 2021 | 3539 | 0.030 |
Why?
|
Cytoplasm | 1 | 2018 | 1516 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2023 | 1889 | 0.030 |
Why?
|
Pyrazines | 1 | 2019 | 1199 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2013 | 12626 | 0.030 |
Why?
|
Aminopyridines | 1 | 2017 | 564 | 0.030 |
Why?
|
Genotype | 2 | 2024 | 12960 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2015 | 6216 | 0.030 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2013 | 1245 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3441 | 0.030 |
Why?
|
S-Adenosylmethionine | 1 | 2015 | 213 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2014 | 358 | 0.030 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2017 | 788 | 0.030 |
Why?
|
Triazoles | 1 | 2019 | 904 | 0.030 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2014 | 213 | 0.030 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2015 | 453 | 0.030 |
Why?
|
Pentosan Sulfuric Polyester | 1 | 1993 | 9 | 0.030 |
Why?
|
Reactive Oxygen Species | 2 | 2014 | 2138 | 0.030 |
Why?
|
Azacitidine | 1 | 2014 | 334 | 0.030 |
Why?
|
Nucleosomes | 1 | 2016 | 484 | 0.030 |
Why?
|
Stem Cells | 2 | 2018 | 3523 | 0.030 |
Why?
|
Physician Self-Referral | 1 | 2012 | 18 | 0.030 |
Why?
|
RNA Polymerase II | 1 | 2017 | 537 | 0.030 |
Why?
|
Stem Cell Transplantation | 1 | 2021 | 1599 | 0.030 |
Why?
|
Molecular Structure | 1 | 2017 | 1895 | 0.030 |
Why?
|
Cartilage | 2 | 1993 | 806 | 0.030 |
Why?
|
Receptors, LDL | 1 | 1995 | 488 | 0.030 |
Why?
|
Peptide Fragments | 3 | 2007 | 5125 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2017 | 789 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3804 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 2 | 1993 | 2753 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2018 | 1949 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 886 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2018 | 58995 | 0.020 |
Why?
|
YY1 Transcription Factor | 1 | 2012 | 59 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1677 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2014 | 2873 | 0.020 |
Why?
|
Cytogenetics | 2 | 2005 | 198 | 0.020 |
Why?
|
Nebulizers and Vaporizers | 1 | 1992 | 137 | 0.020 |
Why?
|
Host-Parasite Interactions | 1 | 2014 | 301 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2007 | 1135 | 0.020 |
Why?
|
Gene Library | 1 | 2014 | 1060 | 0.020 |
Why?
|
Enterocytes | 1 | 2013 | 220 | 0.020 |
Why?
|
Symbiosis | 1 | 2014 | 291 | 0.020 |
Why?
|
rab GTP-Binding Proteins | 1 | 1993 | 251 | 0.020 |
Why?
|
Oligonucleotides | 1 | 2014 | 588 | 0.020 |
Why?
|
Phenylalanine | 1 | 2013 | 365 | 0.020 |
Why?
|
Algorithms | 1 | 2012 | 13981 | 0.020 |
Why?
|
RNA Splicing | 1 | 2016 | 915 | 0.020 |
Why?
|
Valine | 1 | 2013 | 409 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2015 | 724 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2013 | 492 | 0.020 |
Why?
|
Adrenergic beta-Agonists | 1 | 1992 | 345 | 0.020 |
Why?
|
Cloning, Molecular | 2 | 1993 | 4169 | 0.020 |
Why?
|
Gait | 2 | 1993 | 812 | 0.020 |
Why?
|
Stem Cell Factor | 1 | 2011 | 196 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2015 | 1982 | 0.020 |
Why?
|
Macromolecular Substances | 1 | 1993 | 1433 | 0.020 |
Why?
|
Propionates | 1 | 1991 | 182 | 0.020 |
Why?
|
Pyrroles | 1 | 2017 | 1137 | 0.020 |
Why?
|
Clinical Laboratory Techniques | 1 | 2016 | 749 | 0.020 |
Why?
|
Rats | 3 | 1997 | 23711 | 0.020 |
Why?
|
Genes, BRCA1 | 1 | 2014 | 765 | 0.020 |
Why?
|
Federal Government | 1 | 2012 | 267 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2021 | 2640 | 0.020 |
Why?
|
Health Services Misuse | 1 | 2012 | 245 | 0.020 |
Why?
|
Menisci, Tibial | 1 | 1993 | 269 | 0.020 |
Why?
|
Program Development | 1 | 2016 | 1297 | 0.020 |
Why?
|
Antibodies, Helminth | 1 | 2010 | 57 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2011 | 915 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2017 | 818 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 283 | 0.020 |
Why?
|
Multiple Myeloma | 1 | 2008 | 5130 | 0.020 |
Why?
|
Protein Transport | 1 | 2015 | 1964 | 0.020 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2014 | 607 | 0.020 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 444 | 0.020 |
Why?
|
Nitriles | 1 | 2014 | 956 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 21025 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2002 | 6068 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2010 | 276 | 0.020 |
Why?
|
Hemorrhage | 1 | 2001 | 3600 | 0.020 |
Why?
|
Mesothelioma | 1 | 2015 | 807 | 0.020 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2010 | 377 | 0.020 |
Why?
|
Polymorphism, Genetic | 2 | 2016 | 4291 | 0.020 |
Why?
|
Aged | 7 | 2018 | 169152 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 1995 | 1411 | 0.020 |
Why?
|
Osteoblasts | 1 | 2014 | 1142 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 319 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 1741 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3800 | 0.020 |
Why?
|
Organ Specificity | 1 | 1993 | 1955 | 0.020 |
Why?
|
Larva | 1 | 2010 | 509 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2014 | 2061 | 0.020 |
Why?
|
Antibody Affinity | 1 | 2009 | 245 | 0.020 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2010 | 534 | 0.020 |
Why?
|
Biomedical Research | 2 | 2016 | 3426 | 0.020 |
Why?
|
Hybridomas | 1 | 2009 | 442 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2011 | 632 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2018 | 6828 | 0.020 |
Why?
|
Injections, Intra-Articular | 3 | 1993 | 279 | 0.020 |
Why?
|
BRCA1 Protein | 1 | 2014 | 1147 | 0.020 |
Why?
|
Drosophila Proteins | 1 | 1997 | 1699 | 0.020 |
Why?
|
Radiation Tolerance | 1 | 2010 | 480 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2009 | 869 | 0.020 |
Why?
|
Electron Transport Complex IV | 1 | 2007 | 190 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2005 | 15840 | 0.020 |
Why?
|
Leukocytes | 1 | 2015 | 2026 | 0.020 |
Why?
|
Glycoproteins | 1 | 1995 | 2208 | 0.020 |
Why?
|
Middle Aged | 8 | 2018 | 220352 | 0.020 |
Why?
|
Polysomnography | 1 | 2014 | 1825 | 0.020 |
Why?
|
Tibia | 1 | 1993 | 1065 | 0.020 |
Why?
|
Osteoclasts | 1 | 2011 | 711 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39261 | 0.020 |
Why?
|
Limonins | 1 | 2006 | 23 | 0.020 |
Why?
|
Gastric Mucosa | 1 | 2010 | 599 | 0.020 |
Why?
|
Cross Reactions | 1 | 2009 | 818 | 0.020 |
Why?
|
Phenothiazines | 1 | 2006 | 61 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2009 | 1060 | 0.020 |
Why?
|
Visual Acuity | 1 | 2016 | 2643 | 0.020 |
Why?
|
Liver | 2 | 2009 | 7509 | 0.020 |
Why?
|
Affect | 1 | 2014 | 1480 | 0.020 |
Why?
|
Enzyme Activators | 1 | 2006 | 57 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2015 | 1885 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 3735 | 0.020 |
Why?
|
Enzyme Activation | 2 | 2005 | 3602 | 0.020 |
Why?
|
Cell Death | 1 | 2011 | 1672 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2016 | 3215 | 0.020 |
Why?
|
Tetrazolium Salts | 1 | 2005 | 92 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2010 | 2176 | 0.020 |
Why?
|
Adolescent | 5 | 2016 | 87810 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 2005 | 225 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2016 | 3484 | 0.020 |
Why?
|
HLA-A2 Antigen | 1 | 2005 | 211 | 0.020 |
Why?
|
Intracellular Membranes | 1 | 2006 | 389 | 0.020 |
Why?
|
DNA Repair | 1 | 2014 | 2039 | 0.020 |
Why?
|
Mitochondrial Membranes | 1 | 2006 | 172 | 0.020 |
Why?
|
Antigens, Surface | 1 | 2009 | 1608 | 0.010 |
Why?
|
Knee Joint | 1 | 1993 | 1663 | 0.010 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2005 | 92 | 0.010 |
Why?
|
Health Promotion | 1 | 2016 | 2206 | 0.010 |
Why?
|
Heterozygote | 1 | 2011 | 2798 | 0.010 |
Why?
|
Pyrazoles | 1 | 2014 | 1999 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2651 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 2005 | 630 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 2009 | 1529 | 0.010 |
Why?
|
Risk Assessment | 1 | 2005 | 24123 | 0.010 |
Why?
|
Mesenchymal Stem Cells | 1 | 2014 | 1634 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2010 | 1548 | 0.010 |
Why?
|
Arabinofuranosylcytosine Triphosphate | 1 | 2002 | 7 | 0.010 |
Why?
|
DCMP Deaminase | 1 | 2002 | 7 | 0.010 |
Why?
|
Pyrimidine Nucleotides | 1 | 2002 | 7 | 0.010 |
Why?
|
Deoxycytidine Kinase | 1 | 2002 | 11 | 0.010 |
Why?
|
Equilibrative Nucleoside Transporter 1 | 1 | 2002 | 17 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7408 | 0.010 |
Why?
|
Membrane Proteins | 3 | 2007 | 7850 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2015 | 3663 | 0.010 |
Why?
|
Phylogeny | 1 | 2010 | 2775 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 1993 | 2698 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7343 | 0.010 |
Why?
|
Myeloid Cells | 1 | 2007 | 820 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 65017 | 0.010 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2005 | 824 | 0.010 |
Why?
|
Fibroblasts | 1 | 2012 | 4090 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2010 | 4810 | 0.010 |
Why?
|
CpG Islands | 1 | 2006 | 1221 | 0.010 |
Why?
|
Chromosome Banding | 1 | 2001 | 260 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 1991 | 2282 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6544 | 0.010 |
Why?
|
Immunoglobulin G | 2 | 2009 | 4541 | 0.010 |
Why?
|
GTP-Binding Proteins | 2 | 1997 | 951 | 0.010 |
Why?
|
Immunologic Factors | 1 | 2010 | 1588 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2825 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 58741 | 0.010 |
Why?
|
Lymphocytes | 2 | 2007 | 2611 | 0.010 |
Why?
|
Estrogens | 1 | 2006 | 1520 | 0.010 |
Why?
|
Genetic Variation | 1 | 2015 | 6551 | 0.010 |
Why?
|
Drug Resistance | 1 | 2005 | 1617 | 0.010 |
Why?
|
United States | 2 | 2020 | 72461 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2005 | 1765 | 0.010 |
Why?
|
DNA, Plant | 1 | 1998 | 52 | 0.010 |
Why?
|
Blood Platelets | 1 | 2009 | 2520 | 0.010 |
Why?
|
Kidney | 1 | 1993 | 7064 | 0.010 |
Why?
|
Prospective Studies | 2 | 2016 | 54303 | 0.010 |
Why?
|
ADP-Ribosylation Factors | 1 | 1997 | 133 | 0.010 |
Why?
|
Centromere | 1 | 1998 | 213 | 0.010 |
Why?
|
Wnt1 Protein | 1 | 1997 | 120 | 0.010 |
Why?
|
DNA, Ribosomal | 1 | 1998 | 285 | 0.010 |
Why?
|
Karyotyping | 1 | 1998 | 1171 | 0.010 |
Why?
|
Meiosis | 1 | 1998 | 328 | 0.010 |
Why?
|
Asialoglycoproteins | 1 | 1995 | 19 | 0.010 |
Why?
|
LDL-Receptor Related Protein-Associated Protein | 1 | 1995 | 17 | 0.010 |
Why?
|
alpha-Macroglobulins | 1 | 1995 | 60 | 0.010 |
Why?
|
Genomic Library | 1 | 1995 | 189 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2009 | 11071 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7475 | 0.010 |
Why?
|
Chromosomes | 1 | 1998 | 575 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2005 | 5496 | 0.010 |
Why?
|
alpha-Fetoproteins | 1 | 1995 | 222 | 0.010 |
Why?
|
Mitochondria | 1 | 2007 | 3600 | 0.010 |
Why?
|
Medicare | 1 | 2012 | 6786 | 0.010 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2005 | 1628 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1995 | 1055 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 1995 | 751 | 0.010 |
Why?
|
rab1 GTP-Binding Proteins | 1 | 1993 | 5 | 0.010 |
Why?
|
Asthma | 1 | 1992 | 6172 | 0.010 |
Why?
|
Protein Prenylation | 1 | 1993 | 70 | 0.010 |
Why?
|
Sulfur Radioisotopes | 1 | 1993 | 113 | 0.010 |
Why?
|
Terbutaline | 1 | 1992 | 23 | 0.010 |
Why?
|
Apolipoproteins | 1 | 1995 | 320 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1997 | 1173 | 0.010 |
Why?
|
Peak Expiratory Flow Rate | 1 | 1992 | 144 | 0.010 |
Why?
|
Body Patterning | 1 | 1997 | 632 | 0.010 |
Why?
|
Quality of Life | 1 | 2014 | 13308 | 0.010 |
Why?
|
Mutagenesis, Insertional | 1 | 1995 | 652 | 0.010 |
Why?
|
Arthrography | 1 | 1993 | 149 | 0.010 |
Why?
|
Histocytochemistry | 1 | 1993 | 700 | 0.010 |
Why?
|
Albuterol | 1 | 1992 | 212 | 0.010 |
Why?
|
Joints | 1 | 1993 | 321 | 0.010 |
Why?
|
Patella | 1 | 1993 | 313 | 0.010 |
Why?
|
Endocytosis | 1 | 1995 | 959 | 0.010 |
Why?
|
Femur Head | 1 | 1993 | 297 | 0.010 |
Why?
|
Physical Exertion | 1 | 1993 | 662 | 0.010 |
Why?
|
Synovial Membrane | 1 | 1993 | 524 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1998 | 4625 | 0.010 |
Why?
|
Drosophila | 1 | 1997 | 1492 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 1992 | 1156 | 0.010 |
Why?
|
Endoplasmic Reticulum | 1 | 1995 | 1132 | 0.010 |
Why?
|
Synovial Fluid | 1 | 1991 | 395 | 0.010 |
Why?
|
Caenorhabditis elegans | 1 | 1997 | 1444 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2005 | 22053 | 0.000 |
Why?
|
Spleen | 1 | 1973 | 2298 | 0.000 |
Why?
|
Triglycerides | 1 | 1995 | 2476 | 0.000 |
Why?
|
Pregnancy | 1 | 2009 | 29749 | 0.000 |
Why?
|
Cholesterol | 1 | 1995 | 2924 | 0.000 |
Why?
|
Hodgkin Disease | 1 | 1973 | 1378 | 0.000 |
Why?
|
Alzheimer Disease | 1 | 2006 | 8547 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2005 | 26181 | 0.000 |
Why?
|
Obesity | 1 | 2006 | 12922 | 0.000 |
Why?
|
Radiography | 1 | 1993 | 6965 | 0.000 |
Why?
|
Patient Satisfaction | 1 | 1992 | 3448 | 0.000 |
Why?
|
Chronic Disease | 1 | 1992 | 9287 | 0.000 |
Why?
|
Iodine Isotopes | 1 | 1973 | 86 | 0.000 |
Why?
|
Antigen-Antibody Reactions | 1 | 1973 | 346 | 0.000 |
Why?
|
Immune Sera | 1 | 1973 | 613 | 0.000 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1973 | 465 | 0.000 |
Why?
|
Brain | 1 | 1995 | 26951 | 0.000 |
Why?
|
Antigens | 1 | 1973 | 1447 | 0.000 |
Why?
|
Rabbits | 1 | 1973 | 4773 | 0.000 |
Why?
|